Search Within

Benjamin Heath Durham

  1. "Hematologic Malignancies, Division of"
Formats
  1. Journal Article (49)
  2. Meeting Abstract (44)
  3. Correspondence (2)
  4. Research Letter (2)
  5. Review (2)
Groups
  1. Center for Hematologic Malignancies (99)
  2. Department of Medicine (99)
  3. Hematologic Malignancies, Division of (99)
  4. GSK Faculty (94)
  5. Executive Committee, Center for Hematologic Malignancies (93)
  6. Tow Center for Developmental Oncology (TCDO) (84)

More Groups

People
  1. Omar Abdel-Wahab (83)
  2. Eli Diamond (55)
  3. Raajit Rampal (24)
  4. Ahmet Dogan (22)
  5. David Hyman (20)
  6. Mario Lacouture (18)

More People

Years
  1. 2025 (1)
  2. 2024 (3)
  3. 2023 (13)
  4. 2022 (6)
  5. 2021 (7)
  6. 2020 (7)

More Years

Publications
  1. Blood (30)
  2. Pediatric Blood and Cancer (11)
  3. Leukemia (4)
  4. Nature Medicine (4)
  5. Blood Advances (3)
  6. Cancer Discovery (3)

More Publications

Publishers
  1. American Society of Hematology (33)
  2. Nature Publishing Group (16)
  3. Wiley Periodicals, Inc (11)
  4. American Association for Cancer Research (6)
  5. Cell Press (3)
  6. Ferrata Storti Foundation (3)

More Publishers

Results (99)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The effect of methylation on the let-7-BCL2L1-BCL2 axis and the potential use of hypomethylating and BH3 mimetic drugs in histiocytic neoplasms
    Correspondence

    Salmon-Divon, M.; Meyuchas, R.; Shpilberg, O.; Okon, E.; Benhamida, J.; Yabe, M.; Petrova-Drus, K.; Zvida-Bloch, T.; Basood, M.; Mazor, R.; more...
    Leukemia (2025)

    Fulltext@MSK | Save
  • Cell-free DNA from nail clippings as source of normal control for genomic studies in hematologic malignancies
    Journal Article

    Krystel-Whittemore, M.; Petrova-Drus, K.; Ptashkin, R. N.; Ewalt, M. D.; Yao, J.; Liu, Y.; Zhu, M.; Benhamida, J.; Durham, B.; Kumar, J.; more...
    Haematologica (2024)

    Fulltext@MSK | Save
  • Mixed histiocytic neoplasms: A multicentre series revealing diverse somatic mutations and responses to targeted therapy
    Journal Article

    Friedman, J. S.; Durham, B. H.; Reiner, A. S.; Yabe, M.; Petrova-Drus, K.; Dogan, A.; Pulitzer, M.; Busam, K. J.; Francis, J. H.; Rampal, R. K.; more...
    British Journal of Haematology (2024)

    Fulltext@MSK | Save
  • Genome-wide association study identifies the first germline genetic variant associated with Erdheim-Chester disease
    Journal Article

    Martínez-López, J.; Márquez, A.; Pegoraro, F.; Ortiz-Fernández, L.; Acosta-Herrera, M.; Kerick, M.; Gelain, E.; Diamond, E. L.; Durham, B. H.; Abdel-Wahab, O.; more...
    Arthritis & Rheumatology (2024)

    Fulltext@MSK | Save
  • Outcomes with MEK inhibitor therapy among adults with Langerhans cell histiocytosis (LCH): A multi-institutional study from the Adult LCH Working Group for the Histiocyte Society
    Meeting Abstract

    Goyal, G.; Acosta Medina, A. A.; Cao, X.; Bossert, D.; Matthew, P. C.; Makras, P.; Abdel-Wahab, O.; Abeykoon, J. P.; Amerikanou, R.; Bach, C.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • DNA methylation-based classification of hairy cell leukemia and splenic B cell lymphoma
    Meeting Abstract

    Yamaguchi, K.; Abdelbaky, S.; Arons, E.; Cross, M.; Wu, Y. Z.; Weigel, C.; Anghelina, M. I.; Parker, H.; Kibler, A.; Salido, M.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Phase 2 trial of single-agent cobimetinib for adults with histiocytic neoplasms
    Meeting Abstract

    Diamond, E. L.; Durham, B.; Dogan, A.; Yabe, M.; Petrova-Drus, K.; Rampal, R. K.; Ulaner, G.; Lacouture, M.; Rotemberg, V.; Covey, A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Histiocytic neoplasm subtypes differ in their MAP2K1 mutational type
    Research Letter

    Emile, J. F.; Hélias-Rodzewicz, Z.; Durham, B. H.; Héritier, S.; da Silva, M.; Younas, K.; Cohen-Aubart, F.; Abdel-Wahab, O.; Diamond, E. L.; Donadieu, J.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Mutant PIK3CA is a targetable driver alteration in histiocytic neoplasms
    Journal Article

    Durham, B. H.; Hershkovitz-Rokah, O.; Abdel-Wahab, O.; Yabe, M.; Chung, Y. R.; Itchaki, G.; Ben-Sasson, M.; Asher-Guz, V. A.; Groshar, D.; Doe-Tetteh, S. A.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Outcomes after interruption of targeted therapy in patients with histiocytic neoplasms
    Journal Article

    Reiner, A. S.; Durham, B. H.; Yabe, M.; Petrova-Drus, K.; Francis, J. H.; Rampal, R. K.; Lacouture, M. E.; Rotemberg, V.; Abdel-Wahab, O.; Panageas, K. S.; more...
    British Journal of Haematology (2023)

    Fulltext@MSK | Save